The facility in Payson received a Foreign Site Registration Number from Health Canada’s Natural and Non Prescription Health Product Directorate (NNHPD). The agency recently audited Sabinsas facility for compliance with Canada’s Natural Health Product GMP standards and for the compliance of its quality system and was deemed in line with the regulatory specifications. The issuance of Foreign Sire Reference Number 5000311 means Sabinsa can now manufacture products for the Canadian market in the Utah facility. The Utah facility is also NSF certified.
Sabinsa Corporation already had multiple Masterfiles and Natural Product Numbers (NPN) approved for use in Canada, which allows several of its extracts in the form of finished products in the Canadian market. LactoSpore, BioPerine, Curcumin C3 Complex, Curcumin C3 Reduct and ForsLean are among Sabinsa’s products that have been granted NPNs. The most recent Sabinsa proudct to acheive this status is the company’s room temperature stable probiotic, LactoSpore MTCC 5856.
“Availability of the NPNs with Sabinsa’s original, science-backed ingredients and the Foreign Site license for our Utah facility will greatly benefit our customers by considerably reducing the time required for product launches in the Canadian market,” said Sabinsa market director Shaheen Majeed.